New diabetes clinical trial: SGLT2i, Pioglitazone, and Ketone Production in T1D

Published on: July 08, 2025 at 11:00PM
Conditions: Type1diabetes
Interventions: Drug: Dapagliflozin 10mg Tab; Drug: Pioglitazone 15 MG and 30mg; Other: Placebo
Sponsors: The University of Texas Health Science Center at San Antonio; National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Not yet recruiting
https://ift.tt/kTvRg5c